San Diego-based OmniSync, which is backed by Govtech Fund, Longley Capital, General Inception, Keshif Ventures, and angels, said it has received a SBIR Phase III contract. The contract comes rom the US Air
Partillion Bioscience Corporation Announces Seed Financing, Expanded Board, and New Partnership with Alloy Therapeutics streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Syntax Bio’s technology platform uses CRISPR to direct stem cells to become a desired cell type in a process that’s more scalable and less expensive than current methods. The startup is raising a Series A round of financing to further demonstrate the potential of its technology.
OmniSync Awarded a Contract by The Under Secretary of Defense, Research and Engineering to Provide AI-Powered Research Impact Analysis Capabilities tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.